The efficacy of anagliptin in patients with type 2 diabetes mellitus
Not Applicable
- Conditions
- type2 diabetes mellitus
- Registration Number
- JPRN-UMIN000027103
- Lead Sponsor
- Juntendo University Urayasu Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with history of hypersensitivity to anagliptin 2.Patients with diabetic ketoacidosis, diabetic coma, or bofore coma, type1 diabetes 3.Severe infection, before and not long after surgery, or patient with severe trauma 4.Women with during pregnancy , nursing, or pregnant likelihood 5.Patients with severe renal dysfunction ,end stage renal disease during dialysis 6.Patients with severe liver dysfunction 7.Inadequte patient judged by doctor
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method